Oberyszyn TM - Search Results

1

Reduction of scar formation in full-thickness wounds with topical celecoxib treatment.

Wilgus TA, Vodovotz Y, Vittadini E, Clubbs EA, Oberyszyn TM. Wilgus TA, et al. Among authors: oberyszyn tm. Wound Repair Regen. 2003 Jan-Feb;11(1):25-34. doi: 10.1046/j.1524-475x.2003.11106.x. Wound Repair Regen. 2003. PMID: 12581424

2

Chemotherapeutic efficacy of topical celecoxib in a murine model of ultraviolet light B-induced skin cancer.

Wilgus TA, Koki AT, Zweifel BS, Rubal PA, Oberyszyn TM. Wilgus TA, et al. Among authors: oberyszyn tm. Mol Carcinog. 2003 Sep;38(1):33-9. doi: 10.1002/mc.10142. Mol Carcinog. 2003. PMID: 12949841

3

Inhibition of cutaneous ultraviolet light B-mediated inflammation and tumor formation with topical celecoxib treatment.

Wilgus TA, Koki AT, Zweifel BS, Kusewitt DF, Rubal PA, Oberyszyn TM. Wilgus TA, et al. Among authors: oberyszyn tm. Mol Carcinog. 2003 Oct;38(2):49-58. doi: 10.1002/mc.10141. Mol Carcinog. 2003. PMID: 14502644

4

Treatment with 5-fluorouracil and celecoxib displays synergistic regression of ultraviolet light B-induced skin tumors.

Wilgus TA, Breza TS Jr, Tober KL, Oberyszyn TM. Wilgus TA, et al. Among authors: oberyszyn tm. J Invest Dermatol. 2004 Jun;122(6):1488-94. doi: 10.1111/j.0022-202X.2004.22606.x. J Invest Dermatol. 2004. PMID: 15175041 Free article.

5

The impact of cyclooxygenase-2 mediated inflammation on scarless fetal wound healing.

Wilgus TA, Bergdall VK, Tober KL, Hill KJ, Mitra S, Flavahan NA, Oberyszyn TM. Wilgus TA, et al. Among authors: oberyszyn tm. Am J Pathol. 2004 Sep;165(3):753-61. doi: 10.1016/S0002-9440(10)63338-X. Am J Pathol. 2004. PMID: 15331400 Free PMC article.

6

Hydrogen peroxide disrupts scarless fetal wound repair.

Wilgus TA, Bergdall VK, Dipietro LA, Oberyszyn TM. Wilgus TA, et al. Among authors: oberyszyn tm. Wound Repair Regen. 2005 Sep-Oct;13(5):513-9. doi: 10.1111/j.1067-1927.2005.00072.x. Wound Repair Regen. 2005. PMID: 16176460

7

Importance of the EP(1) receptor in cutaneous UVB-induced inflammation and tumor development.

Tober KL, Wilgus TA, Kusewitt DF, Thomas-Ahner JM, Maruyama T, Oberyszyn TM. Tober KL, et al. Among authors: oberyszyn tm. J Invest Dermatol. 2006 Jan;126(1):205-11. doi: 10.1038/sj.jid.5700014. J Invest Dermatol. 2006. PMID: 16417238 Free article.

8

Regulation of scar formation by vascular endothelial growth factor.

Wilgus TA, Ferreira AM, Oberyszyn TM, Bergdall VK, Dipietro LA. Wilgus TA, et al. Among authors: oberyszyn tm. Lab Invest. 2008 Jun;88(6):579-90. doi: 10.1038/labinvest.2008.36. Epub 2008 Apr 21. Lab Invest. 2008. PMID: 18427552 Free PMC article.

9

Ultraviolet light exposure stimulates HMGB1 release by keratinocytes.

Johnson KE, Wulff BC, Oberyszyn TM, Wilgus TA. Johnson KE, et al. Among authors: oberyszyn tm. Arch Dermatol Res. 2013 Nov;305(9):805-15. doi: 10.1007/s00403-013-1401-2. Epub 2013 Aug 13. Arch Dermatol Res. 2013. PMID: 23942756 Free PMC article.

10

Topical application of a selective cyclooxygenase inhibitor suppresses UVB mediated cutaneous inflammation.

Wilgus TA, Ross MS, Parrett ML, Oberyszyn TM. Wilgus TA, et al. Among authors: oberyszyn tm. Prostaglandins Other Lipid Mediat. 2000 Oct;62(4):367-84. doi: 10.1016/s0090-6980(00)00089-7. Prostaglandins Other Lipid Mediat. 2000. PMID: 11060900

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

63 results

Search Page